Finance Watch: 14 Biopharma Companies Raise $1bn From VC, Canadian Government

G2 Bio Launches With $200m, Canada Invests $164m In Resilience

Private Company Edition: More $100m-plus mega-rounds means another billion-dollar week for venture capital deals, including financings for G2 Bio, Hummingbird and Numab. Also, BioTheryX brings in $92m, Vedere launches with $77m and Eliem raises $60m two months after launching with $80m. 

Finance Watch

Private biopharmaceutical companies raised more than $1bn from venture capital, seed financing and government investments during the past week, including Eliem Therapeutics, Inc., which said on 24 May that it closed a $60m series B round just two months after it launched with $80m in VC funding.

Eliem’s $140m in combined financing during such a short span of time gives the company venture capital mega-round status at...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Finance Watch

More from Financing